Gene Delivery System Market Size to Touch Around USD 10.0 billion, at a CAGR of 7.2% from 2023 to 2031: Report by Transparency Market Research, Inc.
Focus on enhancing specificity and reducing side effects drives demand for advanced gene delivery systems.
Wilmington, Delaware, United States, Feb. 13, 2024 (GLOBE NEWSWIRE) — Transparency Market Research Inc. – The global gene delivery system market is estimated to flourish at a CAGR of 7.2% from 2023 to 2031. Transparency Market Research projects that the overall sales revenue for gene delivery system is estimated to reach US$ 10.0 billion by the end of 2031.
Increased patient advocacy and awareness regarding gene therapies drive demand for advanced delivery systems, influencing market dynamics and encouraging research and development efforts. Integration of gene delivery systems with complementary technologies such as nanotechnology and artificial intelligence enhances efficiency and precision, opening new avenues for therapeutic applications and market expansion.
Get Sample PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=41636
Some prominent players are as follows:
- Novartis AG
- Amgen Inc.
- Oxford Biomedica PLC
- Sibiono GeneTech Co. Ltd.
- Shanghai Sunway Biotech Co. Ltd.
- Pfizer Inc.
- Bayer AG
- Johnson & Johnson Services Inc.
- Human Stem Cells Institute
Rapid economic development in emerging markets creates opportunities for market penetration and expansion, as healthcare infrastructure improves and affordability of gene therapies increases, particularly in regions like Latin America, Asia Pacific, and Africa. The paradigm shift towards personalized medicine emphasizes the need for tailored treatment approaches, driving demand for customizable gene delivery systems that can cater to individual patient needs, shaping market trends and preferences.
Key Findings of the Market Report
- Among gene delivery systems, adeno-associated virus vector and non-viral gene delivery, particularly physical methods, lead the market due to safety, efficiency, and versatility.
- Oncology stands out as the leading application segment in the gene delivery system market, driven by the demand for innovative cancer therapies.
- Injectable route of administration leads the gene delivery system market due to direct delivery to target tissues, enhancing efficacy and therapeutic outcomes.
Gene Delivery System Market Growth Drivers & Trends
- Rapid progress in CRISPR and other gene editing tools enhances the demand for efficient gene delivery systems, driving market growth.
- Surge in funding for biotechnological research accelerates innovation in gene therapies, fostering market expansion.
- Rising incidence of genetic diseases propels the need for effective gene delivery systems, spurring market demand.
- Collaborative efforts between pharmaceutical companies and research institutions amplify research capabilities, fueling the development and commercialization of gene delivery technologies.
- Widening applications of gene delivery systems in diverse therapeutic areas, including oncology and rare diseases, contribute to market growth as personalized medicine gains prominence.
Global Gene Delivery System Market: Regional Profile
- North America commands a significant share, propelled by advanced healthcare infrastructure, substantial R&D investments, and favorable regulatory frameworks. Leading players such as Thermo Fisher Scientific and Lonza Group bolster the region’s dominance through innovation and strategic collaborations. The presence of renowned research institutions and biotech hubs further amplifies North America’s influence in gene therapy development and commercialization.
- In Europe, a robust regulatory environment and emphasis on biotechnology research fuel market growth. Companies like Merck KGaA and Oxford Biomedica spearhead innovation, leveraging academic-industry partnerships and government support. The region’s strong focus on personalized medicine and patient-centric healthcare drives adoption of gene delivery systems for diverse therapeutic applications.
- Asia Pacific emerges as a dynamic market hub, characterized by rapid technological advancements and increasing healthcare investments. Rising prevalence of genetic disorders and government initiatives promoting biotechnology foster market expansion. Key players like Japan’s Takara Bio Inc. and China’s GenScript Biotech Corporation contribute to regional growth, capitalizing on burgeoning demand and expanding access to advanced gene delivery solutions.
Ask Expert for the Research Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=41636
Gene Delivery System Market: Competitive Landscape
The gene delivery system market is dynamic, driven by continuous innovation and the quest for effective therapies. Major players like Thermo Fisher Scientific, Lonza Group, and Merck KGaA dominate the landscape with diverse product portfolios and robust R&D capabilities. Emerging contenders such as Oxford Biomedica and Sangamo Therapeutics challenge the status quo with groundbreaking technologies and novel approaches.
Collaboration and strategic partnerships amplify competition, fostering a climate of accelerated development and commercialization. With increasing demand for gene therapies across diverse therapeutic areas, the competitive landscape continues to evolve, poised for further expansion and transformation in the pursuit of medical breakthroughs.
- Amgen Inc. leads in biotechnology, focusing on transformative medicines to tackle critical illnesses like cancer, cardiovascular disease, and autoimmune disorders. Their innovative therapies aim to improve patients’ lives, offering hope and healing. Amgen’s dedication to scientific excellence drives groundbreaking discoveries and advancements in healthcare globally.
- Oxford Biomedica PLC is a pioneering gene and cell therapy company, revolutionizing treatment options for severe diseases like cancer and neurological disorders. With cutting-edge technology and a commitment to innovation, Oxford Biomedica develops transformative therapies, driving progress in personalized medicine and improving patient outcomes worldwide.
Gene Delivery System Market: Key Segments
By Delivery System
- Viral Gene Delivery
- Adenovirus Vector
- Lentivirus Vector
- Retrovirus Vector
- Adeno-associated Virus Vector
- Sendai Virus Vector
- Herpes Simplex Virus Vector
- Non-viral Gene Delivery
- Natural Organic Compounds
- Physical Methods
- Chemical Methods
- Combined Hybrid Delivery
- Infectious Diseases
By Route of Administration
- North America
- Latin America
- Asia Pacific
- Middle East & Africa
Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=41636<ype=S
More Trending Reports by Transparency Market Research –
Acute Migraine Treatment Market: The global industry was valued at US$ 2.1 Bn in 2021 and it is projected to advance at a CAGR of 15.1% from 2022 to 2031 and reach more than US$ 7.9 Bn by the end of 2031
Dental Anesthetics Market: The global industry was valued at US$ 705.5 Mn in 2021 and it is projected to grow at a CAGR of 2.6% from 2022 to 2031 and reach more than US$ 904.1 Mn by the end of 2031
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Follow Us: LinkedIn| Twitter| Blog | YouTube
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.